[Skip to Content]
[Skip to Content Landing]
Views 527
Citations 0
Medical News and Perspectives
June 26, 2013

Continuing Antithrombotics Advised for Stroke Survivors During Certain Procedures

JAMA. 2013;309(24):2537. doi:10.1001/jama.2013.7698

Patients with a prior ischemic stroke or transient ischemic attacks are prescribed antiplatelet (aspirin) or anticoagulation (warfarin) agents to reduce the risk of future thromboembolic events. Because these medications increase risk for bleeding, questions remain about whether such patients should continue to take them when undergoing invasive procedures that involve an inherent increased risk of bleeding. The American Academy of Neurology offers some answers in a guideline published online May 28 (http://tinyurl.com/lfkeanp).

First Page Preview View Large
First page PDF preview
First page PDF preview
×